参考文献:
KugeratskiFG, Hodge K, Lilla S, McAndrews KM, Zhou X, Hwang RF, Zanivan S, Kalluri R. Quantitative proteomics identifies the core proteome of exosomes with syntenin-1 as the highest abundant protein and a putative universal biomarker. NatCell Biol. 2021 Jun;23(6):631-641. doi: 10.1038/s41556-021-00693-y.Epub 2021 Jun 9. PMID: 34108659.
附件已隐藏,回复该贴可查看附件
RaghuKalluri教授发表的外泌体相关文章:
Melo, S. A., et al. (2014)."Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and PromoteTumorigenesis." Cancer Cell 26(5): 707-721.(https://www.exosomemed.com/395.html)
Melo, S. A., et al. (2015)."Glypican-1 identifies cancer exosomes and detects early pancreaticcancer." Nature.
Kalluri, R. (2016). "The biologyand function of exosomes in cancer." J Clin Invest 126(4):1208-1215.
Kamerkar, S., et al. (2017)."Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreaticcancer." Nature (https://www.exosomemed.com/3085.html)
Kurywchak, P. and R. Kalluri (2017)."An evolving function of DNA-containing exosomes in chemotherapy-inducedimmune response." Cell Res 27(6): 722-723.
Yang, S., et al. (2017)."Detection of Mutant KRAS and TP53 DNA in Circulating Exosomes fromHealthy Individuals and Patients with Pancreatic Cancer." CancerBiol Ther: 0.
Kurywchak, P., et al. (2018). "Theemerging roles of exosomes in the modulation of immune responses incancer." Genome Med 10(1): 23.
Mendt, M., et al. (2018)."Generation and testing of clinical-grade exosomes for pancreaticcancer." JCI Insight 3(8).
LeBleu, V. S. and R. Kalluri (2019)."Exosomes Exercise Inhibition of Anti-Tumor Immunity duringChemotherapy." Immunity 50(3): 547-549.
McAndrews, K. M. and R. Kalluri (2019)."Mechanisms associated with biogenesis of exosomes in cancer." MolCancer 18(1): 52.
McAndrews, K. M. and R. Kalluri (2019)."Nischarin Regulates Secretion of Exosomes and Cancer Progression." CancerRes 79(9): 2099-2101.
McAndrews, K. M., et al. (2019)."SIRT1 Regulates Lysosome Function and Exosome Secretion." DevCell 49(3): 302-303.
Kalluri, R. and V. S. LeBleu (2020)."The biology, function, and biomedical applications of exosomes." Science367(6478).(https://www.exosomemed.com/6772.html)
LeBleu, V. S. and R. Kalluri (2020)."Exosomes as a Multicomponent Biomarker Platform in Cancer." TrendsCancer.
LeBleu VS, Kalluri R. Exosomes as aMulticomponent Biomarker Platform in Cancer. Trends Cancer.2020 Sep;6(9):767-774. Epub 2020 Apr 16. PMID: 32307267.
Chronopoulos A, Kalluri R. Emergingrole of bacterial extracellular vesicles in cancer. Oncogene.2020 Nov;39(46):6951-6960. Epub 2020 Oct 15. PMID: 33060855.
Kugeratski FG, Kalluri R. Exosomes asmediators of immune regulation and immunotherapy in cancer. FEBS J.2021 Jan;288(1):10-35. PMID: 32910536.
McAndrews KM, Dowlatshahi DP, Dai J,Becker LM, Hensel J, Snowden LM, Leveille JM, Brunner MR, Holden KW, HopkinsNS, Harris AM, Kumpati J, Whitt MA, Lee JJ, Ostrosky-Zeichner LL, Papanna R,LeBleu VS, Allison JP, Kalluri R. Heterogeneous antibodies against SARS-CoV-2spike receptor binding domain and nucleocapsid with implications for COVID-19immunity. JCI Insight. 2020 Sep 17;5(18):e142386. PMID:32796155
Hensel J, McAndrews KM, McGrail DJ,Dowlatshahi DP, LeBleu VS, Kalluri R. Protection against SARS-CoV-2 by BCGvaccination is not supported by epidemiological analyses. Sci Rep.2020 Oct 27;10(1):18377. PMID: 33110184.